74 related articles for article (PubMed ID: 22451061)
1. Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372.
Lai JH; She TF; Juang YM; Tsay YG; Huang AH; Yu SL; Chen JJ; Lai CC
Electrophoresis; 2012 Feb; 33(4):675-88. PubMed ID: 22451061
[TBL] [Abstract][Full Text] [Related]
2. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
[TBL] [Abstract][Full Text] [Related]
6. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
8. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
[TBL] [Abstract][Full Text] [Related]
9. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
[TBL] [Abstract][Full Text] [Related]
10. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X
Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446
[TBL] [Abstract][Full Text] [Related]
12. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
14. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection.
Yao H; Zhang Z; Xiao Z; Chen Y; Li C; Zhang P; Li M; Liu Y; Guan Y; Yu Y; Chen Z
Lung Cancer; 2009 Jul; 65(1):41-8. PubMed ID: 19058872
[TBL] [Abstract][Full Text] [Related]
15. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
17. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteome analysis of three mouse lung adenocarcinoma CMT cell lines with different metastatic potential by two-dimensional gel electrophoresis and mass spectrometry.
Zhang K; Wrzesinski K; Stephen JF; Larsen PM; Zhang X; Roepstorff P
Proteomics; 2008 Dec; 8(23-24):4932-45. PubMed ID: 19003861
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
20. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
